Produktname:4,5,6,7-tetradeuterio-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione

IUPAC Name:2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro(²H₄)-1H-isoindole-1,3-dione

CAS:1219177-18-0
Molekulare Formel:C13H6D4N2O4
Reinheit:95%+
Katalognummer:CM340807
Molekulargewicht:262.26

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM340807-10mg 5-6 Weeks ƅŭŭŭ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:1219177-18-0
Molekulare Formel:C13H6D4N2O4
Schmelzpunkt:-
SMILES-Code:O=C1N(C(CC2)C(NC2=O)=O)C(C3=C1C([2H])=C([2H])C([2H])=C3[2H])=O
Dichte:
Katalognummer:CM340807
Molekulargewicht:262.26
Siedepunkt:
Mdl-Nr.:
Lagerung:

Category Infos

PROTAC-E3 Ligase Ligands
Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptidic small-molecule E3 ligase ligands revolutionized the field and ushered in the design of drug-like PROTACs with potent and selective degradation activity.
PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
Proteolysis-Targeting Chimeras | PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
PROTAC (Proteolysis-Targeting Chimeras) is a promising approach in drug discovery that involves the use of small molecules to target specific proteins for degradation by the cellular machinery.